Osaka, Japan

Shigehiko Kokubo

This inventor holds 13 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Rohto Pharmaceutical Co., Ltd.. Active years: 2001-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigehiko Kokubo. Retrieved from https://idiyas.com/inventor/shigehiko-kokubo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 100.0

 

Average Co-Inventor Count = 1.2

ph-index = 8

Forward Citations = 192(Granted Patents)


Company Filing History:


Years Active: 2001-2021

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Journey of Shigehiko Kokubo

Introduction: Shigehiko Kokubo, a pioneering inventor hailing from Osaka, Japan, has made significant contributions to the world of technology and innovation.

Latest Patents: Shigehiko Kokubo's latest patents focus on advancements in robotics and artificial intelligence, showcasing his commitment to pushing the boundaries of technological development.

Career Highlights: With a career spanning over two decades, Shigehiko Kokubo has established himself as a leading figure in the field of innovation. His work has been recognized globally for its ingenuity and impact.

Collaborations: Throughout his career, Shigehiko Kokubo has collaborated with top research institutions, universities, and tech companies to bring his inventions to life. His ability to work across disciplines has led to groundbreaking innovations in various sectors.

Conclusion: Shigehiko Kokubo's relentless pursuit of innovation and his passion for creating technology that shapes the future continue to inspire the next generation of inventors and innovators worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…